PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
29-Nov-2023 Qnovia, Inc. announces positive results from first-in-human pharmacokinetic and safety study of lead asset QN-01, a prescription inhaled smoking cessation therapy Qnovia
29-Nov-2023 Valo Therapeutics Announces Regulatory Approval to Expand Phase I Immuno-oncology Trial into Sarcoma Valo Therapeutics
28-Nov-2023 Highly experienced CDMO expert Michel Spagnol appointed Chairman of Astraveus Astraveus SAS
28-Nov-2023 NICE endorses only approved treatment for ultra-rare Wolman disease for children diagnosed under the age of two: Interview Opportunity National Institute for Health and Care Excellence (NICE)
28-Nov-2023 National call for volunteers to test ground-breaking psychedelic treatments for mental health conditions Clerkenwell Health
28-Nov-2023 ACG showcases a concept of a next generation capsule filling machine- AF330 at CPHI and PMEC 2023 ACG
28-Nov-2023 Revvity Launches EONIS Q System Enabling Faster, Simplified Newborn Screening for SMA and SCID Revvity
28-Nov-2023 HBK’s Suzhou Production Site Achieves ISO 13485 Certification HBK
28-Nov-2023 Evaxion to Unveil Potentially Groundbreaking AI-Immunology™ Precision Cancer Vaccine Concept Evaxion Biotech A/S
28-Nov-2023 Ebenbuild to Receive Public Funding Under UBIC Consortium for Digital Lung Twin Project Ebenbuild GmbH
27-Nov-2023 Optima Partners Ltd Launches BioXcelerate AI, Pioneering Health Data Science for Accelerated Drug Discovery and Clinical Development Optima Partners Ltd
27-Nov-2023 SMART researchers pave the way for faster and safer T-cell therapy through novel contamination-detection method SMART
25-Nov-2023 Biotech firm raises £1.25m for human gut model as alternative to animal testing Aelius Biotech
24-Nov-2023 Janssen submits application to EMA for amivantamab-based lung cancer regimen in new indication Janssen
24-Nov-2023 Novartis iptacopan meets primary endpoint in new rare kidney disease trial Novartis
23-Nov-2023 New Immunotherapy for Small Cell Lung Cancer Impresses in Phase II Clinical Trial Karl Landsteiner University of Health Sciences
21-Nov-2023 Pioneering Belgian project ATHENA paves the way for Real-World Data reuse in research and personalized care. ATHENA
21-Nov-2023 Immix Biopharma Announces FDA Approval of IND Application for CAR-T NXC-201, Enabling U.S. Patient Dosing Immix Biopharma, Inc.
21-Nov-2023 iTeos to Present at the Piper Sandler 35th Annual Healthcare Conference iTeos
21-Nov-2023 Cherwell welcomes new recruits as pharma environmental monitoring needs grow Cherwell